Literature DB >> 21598017

Idiopathic deep venous thrombosis and arterial endothelial dysfunction in the elderly.

Gianluigi Mazzoccoli1, Andrea Fontana, Massimo Grilli, Mariangela Pia Dagostino, Massimiliano Copetti, Fabio Pellegrini, Gianluigi Vendemiale.   

Abstract

Arterial and venous thrombosis have always been regarded as different pathologies and epidemiological studies have examined the association between venous thrombosis and indicators of atherosclerosis and/or arterial thromboembolic events. We measured the flow-mediated dilation (FMD), a well-known marker of arterial endothelial dysfunction, in young-middle-aged and old-aged patients with and without unprovoked deep venous thrombosis (DVT). The aim of this study was to investigate whether DVT was a significant predictor for impaired FMD, considering all the patients and young-middle-aged (age < 65 years) and old-aged (age ≥ 65 years) patients separately. FMD was measured in the brachial artery on a population of 120 subjects with the same atherosclerosis risk factors, 68 male and 52 female, 70 young-middle-aged subjects (mean age ± SD 49.5 ± 10.5 years) and 50 old-aged subjects (76.2 ± 7.7 years). Patients with DVT showed a significant decrease of FMD compared to patients without DVT (6.8 ± 5.5% vs. 10.9 ± 3.5%, p < 0.001). Moreover, old-aged patients showed a significant decrease of FMD compared to the young-middle-aged subjects (7.4 ± 4.1% vs. 9.8 ± 5.3%, p = 0.005). In the whole study population, DVT was strongly associated with FMD (risk factors adjusted β = -4.14, p < 0.001). A significant interaction between age and the presence of DVT on predicting FMD was found (p = 0.003) suggesting a differential behavior of DVT as predictor of FMD. In young-middle-aged group, multivariate model confirmed that DVT was the most significant predictor of continuous FMD (β = -6.06, p < 0.001). On the contrary, DVT was no more a predictor of FMD in the old age group (β = -0.73, p = 0.556). Furthermore, old-aged patients without DVT showed a statistically significant decrease of FMD compared to the young-middle-aged subjects without DVT (8.2 ± 2.1% vs. 12.6 ± 2.7%, p<0.001) and old-aged patients with DVT showed a not statistically significant decrease of the FMD compared to the young-middle-aged patients with DVT (6.7 ± 5.3% vs. 6.8 ± 5.7%, p = 0.932). In conclusion, young-middle-aged patients with spontaneous DVT show an impaired FMD, whereas this impairment in old-aged subjects is evident independently from the presence or absence of DVT. Aging per se may be associated with physiologic abnormalities in the systemic arteries and with endothelial dysfunction.

Entities:  

Mesh:

Year:  2011        PMID: 21598017      PMCID: PMC3337930          DOI: 10.1007/s11357-011-9265-x

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  31 in total

1.  Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force.

Authors:  Mary C Corretti; Todd J Anderson; Emelia J Benjamin; David Celermajer; Francois Charbonneau; Mark A Creager; John Deanfield; Helmut Drexler; Marie Gerhard-Herman; David Herrington; Patrick Vallance; Joseph Vita; Robert Vogel
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

2.  Venous and arterial thrombosis: a continuous spectrum of the same disease?

Authors:  Carlos Jerjes-Sanchez
Journal:  Eur Heart J       Date:  2004-11-30       Impact factor: 29.983

Review 3.  Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction--the Hoorn Study.

Authors:  Coen D A Stehouwer; Ronald M A Henry; Jacqueline M Dekker; Giel Nijpels; Robert J Heine; Lex M Bouter
Journal:  Kidney Int Suppl       Date:  2004-11       Impact factor: 10.545

4.  Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease.

Authors:  B Takase; A Uehata; T Akima; T Nagai; T Nishioka; A Hamabe; K Satomura; F Ohsuzu; A Kurita
Journal:  Am J Cardiol       Date:  1998-12-15       Impact factor: 2.778

5.  An association between atherosclerosis and venous thrombosis.

Authors:  Paolo Prandoni; Franca Bilora; Antonio Marchiori; Enrico Bernardi; Francesco Petrobelli; Anthonie W A Lensing; Martin H Prins; Antonio Girolami
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

Review 6.  Impaired endothelial function in hypertensive elderly patients evaluated by high resolution ultrasonography.

Authors:  Y Kimura; M Matsumoto; Y B Den; K Iwai; J Munehira; H Hattori; T Hoshino; K Yamada; K Kawanishi; H Tsuchiya
Journal:  Can J Cardiol       Date:  1999-05       Impact factor: 5.223

7.  Tree-structured prediction for censored survival data and the Cox model.

Authors:  A Ciampi; A Negassa; Z Lou
Journal:  J Clin Epidemiol       Date:  1995-05       Impact factor: 6.437

8.  Impairment of the vasodilatation capability of the brachial artery in patients with idiopathic venous thrombosis.

Authors:  Mateja Kaja Jezovnik; Pavel Poredos; Monika Stalc
Journal:  J Atheroscler Thromb       Date:  2010-08-10       Impact factor: 4.928

9.  Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women.

Authors:  D S Celermajer; K E Sorensen; D J Spiegelhalter; D Georgakopoulos; J Robinson; J E Deanfield
Journal:  J Am Coll Cardiol       Date:  1994-08       Impact factor: 24.094

10.  The relationship between flow-mediated brachial artery vasodilation and coronary vasomotor responses to bradykinin: comparison with those to acetylcholine.

Authors:  Shinro Matsuo; Tetsuya Matsumoto; Hiroyuki Takashima; Naoto Ohira; Tetsunobu Yamane; Yo Yasuda; Yasuhiro Tarutani; Minoru Horie
Journal:  J Cardiovasc Pharmacol       Date:  2004-08       Impact factor: 3.105

View more
  9 in total

1.  Bortezomib induced pulmonary toxicity: a case report and review of the literature.

Authors:  Burcin Saglam; Hakan Kalyon; Murat Ozbalak; Serdar Ornek; Siran Keske; Levent Tabak; Nahit Cakar; Handan Zeren; Saide Aytekin; Yasemin Bolukbasi; Burhan Ferhanoglu
Journal:  Am J Blood Res       Date:  2020-12-15

2.  Endothelial progenitor cells and cardiovascular risk: does ageing trump all other factors?

Authors:  Amaryllis H Van Craenenbroeck; Emeline M Van Craenenbroeck
Journal:  Ann Transl Med       Date:  2016-12

3.  The endothelial tumor suppressor p53 is essential for venous thrombus formation in aged mice.

Authors:  Magdalena L Bochenek; Tobias Bauer; Rajinikanth Gogiraju; Yona Nadir; Amrit Mann; Tanja Schönfelder; Leonie Hünig; Benjamin Brenner; Thomas Münzel; Philip Wenzel; Stavros Konstantinides; Katrin Schäfer
Journal:  Blood Adv       Date:  2018-06-12

4.  Thrombosis as a complication of central venous access in pediatric patients with malignancies: a 5-year single-center experience.

Authors:  Verena Wiegering; Sophie Schmid; Oliver Andres; Clemens Wirth; Armin Wiegering; Thomas Meyer; Beate Winkler; Paul G Schlegel; Matthias Eyrich
Journal:  BMC Hematol       Date:  2014-10-01

5.  Association between previous history of gout attack and risk of deep vein thrombosis - a nationwide population-based cohort study.

Authors:  Chun-Chih Chiu; Yung-Tai Chen; Chien-Yi Hsu; Chun-Chin Chang; Chin-Chou Huang; Hsin-Bang Leu; Szu-Yuan Li; Shu-Chen Kuo; Po-Hsun Huang; Jaw-Wen Chen; Shing-Jong Lin
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

6.  Preoperative deep vein thrombosis in patients with cervical spondylotic myelopathy scheduled for spinal surgery.

Authors:  Le Liu; Yan-Bin Liu; Jian-Min Sun; Hai-Feng Hou; Chen Liang; Tao Li; Heng-Tao Qi
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 7.  Molecular and Clinical Issues about the Risk of Venous Thromboembolism in Older Patients: A Focus on Parkinson's Disease and Parkinsonism.

Authors:  Claudio Tana; Fulvio Lauretani; Andrea Ticinesi; Beatrice Prati; Antonio Nouvenne; Tiziana Meschi
Journal:  Int J Mol Sci       Date:  2018-04-26       Impact factor: 5.923

8.  AGEs/RAGE blockade downregulates Endothenin-1 (ET-1), mitigating Human Umbilical Vein Endothelial Cells (HUVEC) injury in deep vein thrombosis (DVT).

Authors:  Yunxin Zhang; Jianlong Liu; Wei Jia; Xuan Tian; Peng Jiang; Zhiyuan Cheng; Jinyong Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

9.  Relations of arterial stiffness and endothelial dysfunction with incident venous thromboembolism.

Authors:  Darae Ko; Sarah R Preis; Andrew D Johnson; Ramachandran S Vasan; Emelia J Benjamin; Naomi M Hamburg; Gary F Mitchell
Journal:  Thromb Res       Date:  2021-06-19       Impact factor: 10.407

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.